MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2021

    Cerebrospinal fluid levels of oxidative stress measured using diacron-reactive oxygen metabolites and biological antioxidant potential in patients with Parkinson’s disease and progressive supranuclear palsy

    K. Takahashi, K. Iwaoka, K. Takahashi, Y. Suzuki, K. Taguchi, K. Yamahara, T. Maeda (Yahaba, Shiwa, Iwate, Japan)

    Objective: We aimed to evaluate cerebrospinal fluid (CSF) levels of oxidative stress (OS) and antioxidant potential using diacron-reactive oxygen metabolites (d-ROMs) and biological antioxidant potential…
  • MDS Virtual Congress 2021

    Markers of Parkinson-related impulsive-compulsive behaviors in the activity of single units in the subthalamic nucleus

    M. Vissani, F. Micheli, G. Pecchioli, S. Ramat, A. Mazzoni (Pontedera, Italy)

    Objective: To characterize the features of the activity of single neurons of the subthalamic nucleus associated to impulsive-compulsive behaviors (ICBs) in Parkinson’s Disease (PD). Background:…
  • MDS Virtual Congress 2021

    Cellular Modeling of Tyrosine Hydroxylase Deficiency Recapitulates Patient Phenotypes and Response to Treatment.

    A. Tristán-Noguero, I. Fernández-Carassa, C. Bermejo-Casadesús, C. Calatayud, L. Campa, F. Artigas, R. Domingo-Jiménez, M. Pineda, S. Alcántara, A. Raya, R. Artuch, A. García-Cazorla, A. Consiglio (Esplugues de Llobregat, Spain)

    Objective: Characterize a new cellular model of Tyrosine Hydroxylase deficiency (THD) based on induced pluripotent stem cells (iPSCs) to better understand the pathophysiology and test…
  • MDS Virtual Congress 2021

    Medication effects and validity of home-based freezing tests in Parkinson’s disease

    D. Zoetewei, P. Ginis, T. Herman, D. Denk, M. Brozgol, P. Thumm, J. Hausdorff, A. Nieuwboer (Leuven, Belgium)

    Objective: Determine the validity of a ‘freezing-provoking protocol’ (FOG-PP) in the home setting and assess the effects of medication on freezing of gait (FOG) during…
  • MDS Virtual Congress 2021

    FEASIBILITY OF THE HOME-BASED DANCE EXERCISE FOR ADULTS WITH MODERATE PARKINSON’S DISEASE – A PILOT STUDY CASE REPORT

    M. Ferreira, A. da Silva, B. Yamaguchi, S. Mathur, V. Israel (Toronto, Canada)

    Objective: To explore the feasibility of a home-based dance exercise for adults with moderate Parkinson’s Disease (PD) on balance, functional mobility, quality of life (QOL),…
  • MDS Virtual Congress 2021

    Exercise habits of People with Parkinson’s across different ethnic populations

    A. Podlewska, A. Sauerbier, D. van Wamelen, L. Batzu, V. Leta, I. Subramanian, K. Ray Chaudhuri (London, United Kingdom)

    Objective: To investigate exercise habits across different ethnicities of People with Parkinson’s. Background: There is evidence that exercise is beneficial for People with Parkinson’s (PwP)…
  • MDS Virtual Congress 2021

    Development of a remote physical exercise program during COVID-19 pandemic for individuals with Parkinson’s disease

    C. Torriani-Pasin, T. Freitas, V. Domingues, B. Araújo, G. Palma, M. Makhoul, R. Andreotti, L. Mochizuki (Sao Paulo, Brazil)

    Objective: To describe the development process of adaptation of in-person physical exercise program to telemonitoring format to people with Parkinson’s disease (PD). Background: People with…
  • MDS Virtual Congress 2021

    ‘In It Together’: including carers to improve outcomes for people with Parkinson’s

    K. Mcewan, A. Hand, A. Clarke, K. Brittain, A. Bate, S. Dalkin, S. Mccarthy, R. Bradford, C. Allen, K. Mcdonald (Newcastle Upon Tyne, United Kingdom)

    Objective: Informal carers of people with Parkinson’s (PwP) can undertake multiple roles, including personal, emotional, financial, or household tasks [1] increasing as the condition progresses.…
  • MDS Virtual Congress 2021

    Impact of ALXN1840 on the neurological symptoms of Wilson disease: secondary outcomes of a phase 2, open-label, single-arm study

    A. Członkowska, S. Moseley, E. Swenson, D. Bega, P. Hedera, D. Nicholl, J. Bronstein (Warsaw, Poland)

    Objective: To evaluate neurological efficacy outcomes of ALXN1840 treatment in adults with Wilson disease (WD) from a phase 2, open-label, single-arm study (NCT02273596). Background: WD…
  • MDS Virtual Congress 2021

    Does MDS-UPDRS provide greater sensitivity to mild disease than UPDRS for assessing motor severity in early Parkinson’s disease?

    D. Hall, M. Tosin, C. Patterson, G. Stebbins (Chicago, USA)

    Objective: To test whether The Movement Disorder Society revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS) Part III (Motor Examination) items provide increased sensitivity…
  • « Previous Page
  • 1
  • …
  • 118
  • 119
  • 120
  • 121
  • 122
  • …
  • 132
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Survey-Based study of marijuana used in Parkinson’s Disease patients
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Life expectancy with and without Parkinson’s disease in the general population
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley